 | • レポートコード：GIR-105X06461 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エトドラクのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エトドラクの種類別市場規模（錠剤、カプセル）、用途別市場規模（関節リウマチ、変形性関節症、軽度～中等度疼痛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エトドラクの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amneal Pharmaceuticals、Genpharm Ulc、Physicians Total Care、Actavis Elizabeth 、Blenheim Pharmacal、Teva 、Taro Pharmaceuticals 、Apotex、PD-Rx Pharmaceuticals、Nucare Pharmaceuticals、Eon Labs ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、カプセル ・用途別分析2016年-2026年：関節リウマチ、変形性関節症、軽度～中等度疼痛、その他 ・エトドラクの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エトドラクのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エトドラクのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エトドラクの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エトドラクの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Etodolac market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Etodolac size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Etodolac market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Etodolac market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsules
Market segment by Application can be divided into
Rheumatoid Arthritis
Osteoarthritis
Mild to Moderate Pain
Other
The key market players for global Etodolac market are listed below:
Amneal Pharmaceuticals
Genpharm Ulc
Physicians Total Care
Actavis Elizabeth
Blenheim Pharmacal
Teva
Taro Pharmaceuticals
Apotex
PD-Rx Pharmaceuticals
Nucare Pharmaceuticals
Eon Labs
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Etodolac Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Etodolac Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets
1.2.3 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Etodolac Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Mild to Moderate Pain
1.3.5 Other
1.4 Global Etodolac Market Size & Forecast
1.4.1 Global Etodolac Sales in Value (2016-2026))
1.4.2 Global Etodolac Sales in Volume (2016-2026)
1.4.3 Global Etodolac Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Etodolac Production Capacity Analysis
1.5.1 Global Etodolac Total Production Capacity (2016-2026)
1.5.2 Global Etodolac Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Etodolac Market Drivers
1.6.2 Etodolac Market Restraints
1.6.3 Etodolac Trends Analysis
2 Manufacturers Profiles
2.1 Amneal Pharmaceuticals
2.1.1 Amneal Pharmaceuticals Details
2.1.2 Amneal Pharmaceuticals Major Business
2.1.3 Amneal Pharmaceuticals Etodolac Product and Services
2.1.4 Amneal Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Genpharm Ulc
2.2.1 Genpharm Ulc Details
2.2.2 Genpharm Ulc Major Business
2.2.3 Genpharm Ulc Etodolac Product and Services
2.2.4 Genpharm Ulc Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Physicians Total Care
2.3.1 Physicians Total Care Details
2.3.2 Physicians Total Care Major Business
2.3.3 Physicians Total Care Etodolac Product and Services
2.3.4 Physicians Total Care Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Actavis Elizabeth
2.4.1 Actavis Elizabeth Details
2.4.2 Actavis Elizabeth Major Business
2.4.3 Actavis Elizabeth Etodolac Product and Services
2.4.4 Actavis Elizabeth Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Blenheim Pharmacal
2.5.1 Blenheim Pharmacal Details
2.5.2 Blenheim Pharmacal Major Business
2.5.3 Blenheim Pharmacal Etodolac Product and Services
2.5.4 Blenheim Pharmacal Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Etodolac Product and Services
2.6.4 Teva Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Taro Pharmaceuticals
2.7.1 Taro Pharmaceuticals Details
2.7.2 Taro Pharmaceuticals Major Business
2.7.3 Taro Pharmaceuticals Etodolac Product and Services
2.7.4 Taro Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Apotex
2.8.1 Apotex Details
2.8.2 Apotex Major Business
2.8.3 Apotex Etodolac Product and Services
2.8.4 Apotex Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 PD-Rx Pharmaceuticals
2.9.1 PD-Rx Pharmaceuticals Details
2.9.2 PD-Rx Pharmaceuticals Major Business
2.9.3 PD-Rx Pharmaceuticals Etodolac Product and Services
2.9.4 PD-Rx Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Nucare Pharmaceuticals
2.10.1 Nucare Pharmaceuticals Details
2.10.2 Nucare Pharmaceuticals Major Business
2.10.3 Nucare Pharmaceuticals Etodolac Product and Services
2.10.4 Nucare Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Eon Labs
2.11.1 Eon Labs Details
2.11.2 Eon Labs Major Business
2.11.3 Eon Labs Etodolac Product and Services
2.11.4 Eon Labs Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Etodolac Sales by Manufacturer
3.1 Global Etodolac Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Etodolac Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Etodolac
3.4 Market Concentration Rate
3.4.1 Top 3 Etodolac Manufacturer Market Share
3.4.2 Top 6 Etodolac Manufacturer Market Share
3.5 Global Etodolac Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Etodolac Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Etodolac Market Size by Region
4.1.1 Global Etodolac Sales in Volume by Region (2016-2026)
4.1.2 Global Etodolac Revenue by Region (2016-2026)
4.2 North America Etodolac Revenue (2016-2026)
4.3 Europe Etodolac Revenue (2016-2026)
4.4 Asia-Pacific Etodolac Revenue (2016-2026)
4.5 South America Etodolac Revenue (2016-2026)
4.6 Middle East and Africa Etodolac Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Etodolac Sales in Volume by Type (2016-2026)
5.2 Global Etodolac Revenue by Type (2016-2026)
5.3 Global Etodolac Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Etodolac Sales in Volume by Application (2016-2026)
6.2 Global Etodolac Revenue by Application (2016-2026)
6.3 Global Etodolac Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Etodolac Sales by Type (2016-2026)
7.2 North America Etodolac Sales by Application (2016-2026)
7.3 North America Etodolac Market Size by Country
7.3.1 North America Etodolac Sales in Volume by Country (2016-2026)
7.3.2 North America Etodolac Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Etodolac Sales by Type (2016-2026)
8.2 Europe Etodolac Sales by Application (2016-2026)
8.3 Europe Etodolac Market Size by Country
8.3.1 Europe Etodolac Sales in Volume by Country (2016-2026)
8.3.2 Europe Etodolac Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Etodolac Sales by Type (2016-2026)
9.2 Asia-Pacific Etodolac Sales by Application (2016-2026)
9.3 Asia-Pacific Etodolac Market Size by Region
9.3.1 Asia-Pacific Etodolac Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Etodolac Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Etodolac Sales by Type (2016-2026)
10.2 South America Etodolac Sales by Application (2016-2026)
10.3 South America Etodolac Market Size by Country
10.3.1 South America Etodolac Sales in Volume by Country (2016-2026)
10.3.2 South America Etodolac Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Etodolac Sales by Type (2016-2026)
11.2 Middle East & Africa Etodolac Sales by Application (2016-2026)
11.3 Middle East & Africa Etodolac Market Size by Country
11.3.1 Middle East & Africa Etodolac Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Etodolac Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Etodolac Typical Distributors
12.3 Etodolac Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Etodolac Revenue by Type, (USD Million), 2021-2026
Table 2. Global Etodolac Revenue by Application, (USD Million), 2021-2026
Table 3. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Amneal Pharmaceuticals Major Business
Table 5. Amneal Pharmaceuticals Etodolac Product and Services
Table 6. Amneal Pharmaceuticals Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Genpharm Ulc Basic Information, Manufacturing Base and Competitors
Table 8. Genpharm Ulc Major Business
Table 9. Genpharm Ulc Etodolac Product and Services
Table 10. Genpharm Ulc Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Physicians Total Care Basic Information, Manufacturing Base and Competitors
Table 12. Physicians Total Care Major Business
Table 13. Physicians Total Care Etodolac Product and Services
Table 14. Physicians Total Care Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Actavis Elizabeth Basic Information, Manufacturing Base and Competitors
Table 16. Actavis Elizabeth Major Business
Table 17. Actavis Elizabeth Etodolac Product and Services
Table 18. Actavis Elizabeth Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Blenheim Pharmacal Basic Information, Manufacturing Base and Competitors
Table 20. Blenheim Pharmacal Major Business
Table 21. Blenheim Pharmacal Etodolac Product and Services
Table 22. Blenheim Pharmacal Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Major Business
Table 25. Teva Etodolac Product and Services
Table 26. Teva Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Taro Pharmaceuticals Major Business
Table 29. Taro Pharmaceuticals Etodolac Product and Services
Table 30. Taro Pharmaceuticals Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Apotex Basic Information, Manufacturing Base and Competitors
Table 32. Apotex Major Business
Table 33. Apotex Etodolac Product and Services
Table 34. Apotex Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. PD-Rx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. PD-Rx Pharmaceuticals Major Business
Table 37. PD-Rx Pharmaceuticals Etodolac Product and Services
Table 38. PD-Rx Pharmaceuticals Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Nucare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Nucare Pharmaceuticals Major Business
Table 41. Nucare Pharmaceuticals Etodolac Product and Services
Table 42. Nucare Pharmaceuticals Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Eon Labs Basic Information, Manufacturing Base and Competitors
Table 44. Eon Labs Major Business
Table 45. Eon Labs Etodolac Product and Services
Table 46. Eon Labs Etodolac Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Etodolac Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Etodolac Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Etodolac, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Etodolac Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Etodolac Production Site of Key Manufacturer
Table 52. Global Etodolac Sales by Region (2016-2021e) & (K Pcs)
Table 53. Global Etodolac Sales by Region (2021-2026) & (K Pcs)
Table 54. Global Etodolac Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Etodolac Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Etodolac Sales by Type (2016-2021e) & (K Pcs)
Table 57. Global Etodolac Sales by Type (2021-2026) & (K Pcs)
Table 58. Global Etodolac Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Etodolac Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Etodolac Price by Type (2016-2021e) & (USD/Pcs)
Table 61. Global Etodolac Price by Type (2021-2026) & (USD/Pcs)
Table 62. Global Etodolac Sales by Application (2016-2021e) & (K Pcs)
Table 63. Global Etodolac Sales by Application (2021-2026) & (K Pcs)
Table 64. Global Etodolac Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Etodolac Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Etodolac Price by Application (2016-2021e) & (USD/Pcs)
Table 67. Global Etodolac Price by Application (2021-2026) & (USD/Pcs)
Table 68. North America Etodolac Sales by Country (2016-2021e) & (K Pcs)
Table 69. North America Etodolac Sales by Country (2021-2026) & (K Pcs)
Table 70. North America Etodolac Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Etodolac Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Etodolac Sales by Type (2016-2021e) & (K Pcs)
Table 73. North America Etodolac Sales by Type (2021-2026) & (K Pcs)
Table 74. North America Etodolac Sales by Application (2016-2021e) & (K Pcs)
Table 75. North America Etodolac Sales by Application (2021-2026) & (K Pcs)
Table 76. Europe Etodolac Sales by Country (2016-2021e) & (K Pcs)
Table 77. Europe Etodolac Sales by Country (2021-2026) & (K Pcs)
Table 78. Europe Etodolac Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Etodolac Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Etodolac Sales by Type (2016-2021e) & (K Pcs)
Table 81. Europe Etodolac Sales by Type (2021-2026) & (K Pcs)
Table 82. Europe Etodolac Sales by Application (2016-2021e) & (K Pcs)
Table 83. Europe Etodolac Sales by Application (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Etodolac Sales by Region (2016-2021e) & (K Pcs)
Table 85. Asia-Pacific Etodolac Sales by Region (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Etodolac Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Etodolac Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Etodolac Sales by Type (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Etodolac Sales by Type (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Etodolac Sales by Application (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Etodolac Sales by Application (2021-2026) & (K Pcs)
Table 92. South America Etodolac Sales by Country (2016-2021e) & (K Pcs)
Table 93. South America Etodolac Sales by Country (2021-2026) & (K Pcs)
Table 94. South America Etodolac Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Etodolac Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Etodolac Sales by Type (2016-2021e) & (K Pcs)
Table 97. South America Etodolac Sales by Type (2021-2026) & (K Pcs)
Table 98. South America Etodolac Sales by Application (2016-2021e) & (K Pcs)
Table 99. South America Etodolac Sales by Application (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Etodolac Sales by Country (2016-2021e) & (K Pcs)
Table 101. Middle East & Africa Etodolac Sales by Country (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Etodolac Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Etodolac Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Etodolac Sales by Type (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Etodolac Sales by Type (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Etodolac Sales by Application (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Etodolac Sales by Application (2021-2026) & (K Pcs)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Etodolac Typical Distributors
Table 111. Etodolac Typical Customers
List of Figures
Figure 1. Etodolac Picture
Figure 2. Global Etodolac Sales Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Global Etodolac Sales Market Share by Application in 2020
Figure 6. Rheumatoid Arthritis
Figure 7. Osteoarthritis
Figure 8. Mild to Moderate Pain
Figure 9. Other
Figure 10. Global Etodolac Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Etodolac Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Etodolac Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Etodolac Sales (2016-2026) & (K Pcs)
Figure 32. Global Etodolac Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Etodolac Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Etodolac Market Drivers
Figure 35. Etodolac Market Restraints
Figure 36. Etodolac Market Trends
Figure 37. Global Etodolac Sales Market Share by Manufacturer in 2020
Figure 38. Global Etodolac Revenue Market Share by Manufacturer in 2020
Figure 39. Etodolac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Etodolac Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Etodolac Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Etodolac Sales Market Share by Region (2016-2026)
Figure 43. Global Etodolac Revenue Market Share by Region (2016-2026)
Figure 44. North America Etodolac Revenue (2016-2026) & (USD Million)
Figure 45. Europe Etodolac Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Etodolac Revenue (2016-2026) & (USD Million)
Figure 47. South America Etodolac Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Etodolac Revenue (2016-2026) & (USD Million)
Figure 49. Global Etodolac Sales Market Share by Type (2016-2026)
Figure 50. Global Etodolac Revenue Market Share by Type (2016-2026)
Figure 51. Global Etodolac Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Etodolac Sales Market Share by Application (2016-2026)
Figure 53. Global Etodolac Revenue Market Share by Application (2016-2026)
Figure 54. Global Etodolac Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Etodolac Sales Market Share by Country (2016-2026)
Figure 56. North America Etodolac Revenue Market Share by Country (2016-2026)
Figure 57. North America Etodolac Sales Market Share by Type (2016-2026)
Figure 58. North America Etodolac Sales Market Share by Application (2016-2026)
Figure 59. Europe Etodolac Sales Market Share by Country (2016-2026)
Figure 60. Europe Etodolac Revenue Market Share by Country (2016-2026)
Figure 61. Europe Etodolac Sales Market Share by Type (2016-2026)
Figure 62. Europe Etodolac Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Etodolac Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Etodolac Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Etodolac Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Etodolac Sales Market Share by Application (2016-2026)
Figure 67. South America Etodolac Sales Market Share by Country (2016-2026)
Figure 68. South America Etodolac Revenue Market Share by Country (2016-2026)
Figure 69. South America Etodolac Sales Market Share by Type (2016-2026)
Figure 70. South America Etodolac Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Etodolac Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Etodolac Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Etodolac Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Etodolac Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
変形性関節症の痛みの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Osteoarthritis, the most common type of arthritis, is a leading cause of disability. Scope of the Report: This report focuses on the Osteoarthritis Pain in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market b…- 骨関節炎鎮痛剤の世界市場2018-2025 Hip Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Hip Osteoarthritis Pain Medicine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.5% from 2018. In this study, 2017 has been consider…
- 骨関節炎鎮痛剤の世界市場2018-2025 Hip Osteoarthritis Pain Drug is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Hip Osteoarthritis Pain Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.5% from 2018. In this study, 2017 has been considered as th…
- 変形性関節症用痛み止めの世界市場2018-2025 Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Osteoarthritis Pain Medicine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.7% from 2018. In this study, 2017 has been considered as th…
- 変形性関節症用ソリューションの世界市場2018-2025 Osteoarthritis Pain Solution is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Osteoarthritis Pain Solution market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.7% from 2018. In this study, 2017 has been considered as th…